| Year |
Citation |
Score |
| 2023 |
Kaur R, Tada T, Landau NR. Restriction of SARS-CoV-2 replication by receptor transporter protein 4 (RTP4). Mbio. e0109023. PMID 37382452 DOI: 10.1128/mbio.01090-23 |
0.402 |
|
| 2023 |
Tada T, Dcosta BM, Zhou H, Landau NR. Prophylaxis and treatment of SARS-CoV-2 infection by an ACE2 receptor decoy in a preclinical animal model. Iscience. 26: 106092. PMID 36741912 DOI: 10.1016/j.isci.2023.106092 |
0.329 |
|
| 2023 |
Tada T, Dcosta BM, Zhou H, Landau NR. Prophylaxis and Treatment of SARS-CoV-2 infection by an ACE2 Receptor Decoy. Biorxiv : the Preprint Server For Biology. PMID 36656772 DOI: 10.1101/2022.12.31.522401 |
0.327 |
|
| 2022 |
Christie SM, Tada T, Yin Y, Bhardwaj A, Landau NR, Rothenberg E. Single-virus tracking reveals variant SARS-CoV-2 spike proteins induce ACE2-independent membrane interactions. Science Advances. 8: eabo3977. PMID 36490345 DOI: 10.1126/sciadv.abo3977 |
0.345 |
|
| 2020 |
Tada T, Fan C, Chen JS, Kaur R, Stapleford KA, Gristick H, Dcosta BM, Wilen CB, Nimigean CM, Landau NR. An ACE2 Microbody Containing a Single Immunoglobulin Fc Domain Is a Potent Inhibitor of SARS-CoV-2. Cell Reports. 108528. PMID 33326798 DOI: 10.1016/j.celrep.2020.108528 |
0.378 |
|
| 2019 |
Norton TD, Zhen A, Tada T, Kim J, Kitchen S, Landau NR. Lentiviral Vector-Based Dendritic Cell Vaccine Suppresses HIV Replication in Humanized Mice. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 30962161 DOI: 10.1016/J.Ymthe.2019.03.008 |
0.356 |
|
| 2019 |
Tada T, Landau NR, Norton TD. Abstract B121: Checkpoint inhibitor vaccine stimulates antitumor T-cells that block tumor growth Cancer Immunology Research. 7. DOI: 10.1158/2326-6074.Cricimteatiaacr18-B121 |
0.308 |
|
| 2018 |
Vanwalscappel B, Tada T, Landau NR. Toll-like receptor agonist R848 blocks Zika virus replication by inducing the antiviral protein viperin. Virology. 522: 199-208. PMID 30036788 DOI: 10.1016/j.virol.2018.07.014 |
0.313 |
|
| 2018 |
Jáuregui P, Landau NR. DNA damage induces a SAMHD1-mediated block to the infection of macrophages by HIV-1. Scientific Reports. 8: 4153. PMID 29515139 DOI: 10.1038/s41598-018-22432-4 |
0.374 |
|
| 2016 |
Tam K, Schultz M, Reyes-Robles T, Vanwalscappel B, Horton J, Alonzo F, Wu B, Landau NR, Torres VJ. Staphylococcus aureus Leukocidin LukED and HIV-1 gp120 Target Different Sequence Determinants on CCR5. Mbio. 7. PMID 27965453 DOI: 10.1128/Mbio.02024-16 |
0.427 |
|
| 2016 |
Tasker C, Subbian S, Gao P, Couret J, Levine C, Ghanny S, Soteropoulos P, Zhao X, Landau N, Lu W, Chang TL. IFN-ε protects primary macrophages against HIV infection. Jci Insight. 1: e88255. PMID 27942584 DOI: 10.1172/Jci.Insight.88255 |
0.462 |
|
| 2016 |
Bloch N, Gläsker S, Sitaram P, Hofmann H, Shepard CN, Schultz ML, Kim B, Landau NR. A Highly Active Isoform of Lentivirus Restriction Factor SAMHD1 in Mouse. The Journal of Biological Chemistry. PMID 27920203 DOI: 10.1074/Jbc.M116.743740 |
0.353 |
|
| 2016 |
Hofmann H, Vanwalscappel B, Bloch N, Landau NR. TLR7/8 agonist induces a post-entry SAMHD1-independent block to HIV-1 infection of monocytes. Retrovirology. 13: 83. PMID 27905985 DOI: 10.1186/s12977-016-0316-3 |
0.428 |
|
| 2015 |
Simon V, Bloch N, Landau NR. Intrinsic host restrictions to HIV-1 and mechanisms of viral escape. Nature Immunology. 16: 546-53. PMID 25988886 DOI: 10.1038/Ni.3156 |
0.477 |
|
| 2015 |
Jáuregui P, Logue EC, Schultz ML, Fung S, Landau NR. Degradation of SAMHD1 by Vpx Is Independent of Uncoating. Journal of Virology. 89: 5701-13. PMID 25762741 DOI: 10.1128/Jvi.03575-14 |
0.542 |
|
| 2015 |
Norton TD, Miller EA, Bhardwaj N, Landau NR. Vpx-containing dendritic cell vaccine induces CTLs and reactivates latent HIV-1 in vitro. Gene Therapy. 22: 227-36. PMID 25567537 DOI: 10.1038/Gt.2014.117 |
0.459 |
|
| 2015 |
Miller EA, Spadaccia MR, Norton T, Demmler M, Gopal R, O'Brien M, Landau N, Dubensky TW, Lauer P, Brockstedt DG, Bhardwaj N. Attenuated Listeria monocytogenes vectors overcome suppressive plasma factors during HIV infection to stimulate myeloid dendritic cells to promote adaptive immunity and reactivation of latent virus. Aids Research and Human Retroviruses. 31: 127-36. PMID 25376024 DOI: 10.1089/Aid.2014.0138 |
0.473 |
|
| 2014 |
Hakata Y, Miyazawa M, Landau NR. Interactions with DCAF1 and DDB1 in the CRL4 E3 ubiquitin ligase are required for Vpr-mediated G2 arrest. Virology Journal. 11: 108. PMID 24912982 DOI: 10.1186/1743-422X-11-108 |
0.431 |
|
| 2014 |
Huber AD, Michailidis E, Schultz ML, Ong YT, Bloch N, Puray-Chavez MN, Leslie MD, Ji J, Lucas AD, Kirby KA, Landau NR, Sarafianos SG. SAMHD1 has differential impact on the efficacies of HIV nucleoside reverse transcriptase inhibitors. Antimicrobial Agents and Chemotherapy. 58: 4915-9. PMID 24867973 DOI: 10.1128/Aac.02745-14 |
0.48 |
|
| 2014 |
Logue EC, Bloch N, Dhuey E, Zhang R, Cao P, Herate C, Chauveau L, Hubbard SR, Landau NR. A DNA sequence recognition loop on APOBEC3A controls substrate specificity. Plos One. 9: e97062. PMID 24827831 DOI: 10.1371/Journal.Pone.0097062 |
0.549 |
|
| 2014 |
Minkah N, Chavez K, Shah P, Maccarthy T, Chen H, Landau N, Krug LT. Host restriction of murine gammaherpesvirus 68 replication by human APOBEC3 cytidine deaminases but not murine APOBEC3. Virology. 454: 215-26. PMID 24725948 DOI: 10.1016/J.Virol.2014.02.022 |
0.47 |
|
| 2014 |
Landau NR. The innate immune response to HIV-1: to sense or not to sense. Dna and Cell Biology. 33: 271-4. PMID 24665823 DOI: 10.1089/Dna.2014.2378 |
0.431 |
|
| 2014 |
Zhang R, Bloch N, Nguyen LA, Kim B, Landau NR. SAMHD1 restricts HIV-1 replication and regulates interferon production in mouse myeloid cells. Plos One. 9: e89558. PMID 24586870 DOI: 10.1371/Journal.Pone.0089558 |
0.527 |
|
| 2014 |
Bloch N, O'Brien M, Norton TD, Polsky SB, Bhardwaj N, Landau NR. HIV type 1 infection of plasmacytoid and myeloid dendritic cells is restricted by high levels of SAMHD1 and cannot be counteracted by Vpx. Aids Research and Human Retroviruses. 30: 195-203. PMID 23924154 DOI: 10.1089/Aid.2013.0119 |
0.511 |
|
| 2013 |
Hofmann H, Norton TD, Schultz ML, Polsky SB, Sunseri N, Landau NR. Inhibition of CUL4A Neddylation causes a reversible block to SAMHD1-mediated restriction of HIV-1. Journal of Virology. 87: 11741-50. PMID 23986575 DOI: 10.1128/Jvi.02002-13 |
0.793 |
|
| 2013 |
Gramberg T, Kahle T, Bloch N, Wittmann S, Müllers E, Daddacha W, Hofmann H, Kim B, Lindemann D, Landau NR. Restriction of diverse retroviruses by SAMHD1. Retrovirology. 10: 26. PMID 23497255 DOI: 10.1186/1742-4690-10-26 |
0.554 |
|
| 2013 |
Alonzo F, Kozhaya L, Rawlings SA, Reyes-Robles T, DuMont AL, Myszka DG, Landau NR, Unutmaz D, Torres VJ. CCR5 is a receptor for Staphylococcus aureus leukotoxin ED. Nature. 493: 51-5. PMID 23235831 DOI: 10.1038/Nature11724 |
0.411 |
|
| 2013 |
Bobadilla S, Sunseri N, Landau NR. Efficient transduction of myeloid cells by an HIV-1-derived lentiviral vector that packages the Vpx accessory protein. Gene Therapy. 20: 514-20. PMID 22895508 DOI: 10.1038/Gt.2012.61 |
0.785 |
|
| 2013 |
Lahouassa H, Daddacha W, Hofmann H, Ayinde D, Logue EC, Dragin L, Bloch N, Maudet C, Bertrand M, Gramberg T, Pancino G, Priet S, Canard B, Laguette N, Benkirane M, ... ... Landau NR, et al. Erratum: Corrigendum: SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates Nature Immunology. 14: 877-877. DOI: 10.1038/Ni0813-877A |
0.426 |
|
| 2012 |
Hofmann H, Logue EC, Bloch N, Daddacha W, Polsky SB, Schultz ML, Kim B, Landau NR. The Vpx lentiviral accessory protein targets SAMHD1 for degradation in the nucleus. Journal of Virology. 86: 12552-60. PMID 22973040 DOI: 10.1128/Jvi.01657-12 |
0.531 |
|
| 2012 |
Baldauf HM, Pan X, Erikson E, Schmidt S, Daddacha W, Burggraf M, Schenkova K, Ambiel I, Wabnitz G, Gramberg T, Panitz S, Flory E, Landau NR, Sertel S, Rutsch F, et al. SAMHD1 restricts HIV-1 infection in resting CD4(+) T cells. Nature Medicine. 18: 1682-7. PMID 22972397 DOI: 10.1038/Nm.2964 |
0.451 |
|
| 2012 |
Lahouassa H, Daddacha W, Hofmann H, Ayinde D, Logue EC, Dragin L, Bloch N, Maudet C, Bertrand M, Gramberg T, Pancino G, Priet S, Canard B, Laguette N, Benkirane M, ... ... Landau NR, et al. SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nature Immunology. 13: 223-8. PMID 22327569 DOI: 10.1038/Ni.2236 |
0.577 |
|
| 2012 |
Liu R, Chen B, Landau NR. Use of Luciferase Reporter Viruses for Studying HIV Entry. Methods in Molecular Medicine. 17: 35-40. PMID 21380655 DOI: 10.1385/0-89603-369-4:35 |
0.482 |
|
| 2011 |
Logue EC, Taylor KT, Goff PH, Landau NR. The cargo-binding domain of transportin 3 is required for lentivirus nuclear import. Journal of Virology. 85: 12950-61. PMID 21976643 DOI: 10.1128/Jvi.05384-11 |
0.581 |
|
| 2011 |
Sunseri N, O'Brien M, Bhardwaj N, Landau NR. Human immunodeficiency virus type 1 modified to package Simian immunodeficiency virus Vpx efficiently infects macrophages and dendritic cells. Journal of Virology. 85: 6263-74. PMID 21507971 DOI: 10.1128/Jvi.00346-11 |
0.798 |
|
| 2010 |
Gramberg T, Sunseri N, Landau NR. Evidence for an activation domain at the amino terminus of simian immunodeficiency virus Vpx. Journal of Virology. 84: 1387-96. PMID 19923175 DOI: 10.1128/Jvi.01437-09 |
0.8 |
|
| 2009 |
Narvaiza I, Linfesty DC, Greener BN, Hakata Y, Pintel DJ, Logue E, Landau NR, Weitzman MD. Deaminase-independent inhibition of parvoviruses by the APOBEC3A cytidine deaminase. Plos Pathogens. 5: e1000439. PMID 19461882 DOI: 10.1371/Journal.Ppat.1000439 |
0.415 |
|
| 2009 |
Browne EP, Allers C, Landau NR. Restriction of HIV-1 by APOBEC3G is cytidine deaminase-dependent. Virology. 387: 313-21. PMID 19304304 DOI: 10.1016/J.Virol.2009.02.026 |
0.537 |
|
| 2009 |
Gramberg T, Sunseri N, Landau NR. Accessories to the crime: recent advances in HIV accessory protein biology. Current Hiv/Aids Reports. 6: 36-42. PMID 19149995 DOI: 10.1007/S11904-009-0006-Z |
0.783 |
|
| 2007 |
Schröfelbauer B, Hakata Y, Landau NR. HIV-1 Vpr function is mediated by interaction with the damage-specific DNA-binding protein DDB1. Proceedings of the National Academy of Sciences of the United States of America. 104: 4130-5. PMID 17360488 DOI: 10.1073/Pnas.0610167104 |
0.502 |
|
| 2007 |
Fang L, Landau NR. Analysis of Vif-induced APOBEC3G degradation using an alpha-complementation assay. Virology. 359: 162-9. PMID 17049578 DOI: 10.1016/J.Virol.2006.09.013 |
0.357 |
|
| 2006 |
Hakata Y, Landau NR. Reversed functional organization of mouse and human APOBEC3 cytidine deaminase domains. The Journal of Biological Chemistry. 281: 36624-31. PMID 17020885 DOI: 10.1074/Jbc.M604980200 |
0.475 |
|
| 2006 |
Schröfelbauer B, Senger T, Manning G, Landau NR. Mutational alteration of human immunodeficiency virus type 1 Vif allows for functional interaction with nonhuman primate APOBEC3G. Journal of Virology. 80: 5984-91. PMID 16731937 DOI: 10.1128/Jvi.00388-06 |
0.559 |
|
| 2006 |
Chen H, Lilley CE, Yu Q, Lee DV, Chou J, Narvaiza I, Landau NR, Weitzman MD. APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons. Current Biology : Cb. 16: 480-5. PMID 16527742 DOI: 10.1016/J.Cub.2006.01.031 |
0.39 |
|
| 2005 |
Schröfelbauer B, Yu Q, Zeitlin SG, Landau NR. Human immunodeficiency virus type 1 Vpr induces the degradation of the UNG and SMUG uracil-DNA glycosylases. Journal of Virology. 79: 10978-87. PMID 16103149 DOI: 10.1128/Jvi.79.17.10978-10987.2005 |
0.608 |
|
| 2005 |
Navarro F, Bollman B, Chen H, König R, Yu Q, Chiles K, Landau NR. Complementary function of the two catalytic domains of APOBEC3G. Virology. 333: 374-86. PMID 15721369 DOI: 10.1016/J.Virol.2005.01.011 |
0.438 |
|
| 2004 |
Yu Q, Chen D, König R, Mariani R, Unutmaz D, Landau NR. APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication. The Journal of Biological Chemistry. 279: 53379-86. PMID 15466872 DOI: 10.1074/Jbc.M408802200 |
0.534 |
|
| 2004 |
Navarro F, Landau NR. Recent insights into HIV-1 Vif. Current Opinion in Immunology. 16: 477-82. PMID 15245742 DOI: 10.1016/J.Coi.2004.05.006 |
0.559 |
|
| 2004 |
Schröfelbauer B, Yu Q, Landau NR. New insights into the role of Vif in HIV-1 replication. Aids Reviews. 6: 34-9. PMID 15168739 |
0.474 |
|
| 2004 |
Yu Q, König R, Pillai S, Chiles K, Kearney M, Palmer S, Richman D, Coffin JM, Landau NR. Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome. Nature Structural & Molecular Biology. 11: 435-42. PMID 15098018 DOI: 10.1038/Nsmb758 |
0.428 |
|
| 2004 |
Schröfelbauer B, Chen D, Landau NR. A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif). Proceedings of the National Academy of Sciences of the United States of America. 101: 3927-32. PMID 14978281 DOI: 10.1073/Pnas.0307132101 |
0.457 |
|
| 2003 |
Münk C, Landau NR. Production and use of HIV-1 luciferase reporter viruses. Current Protocols in Pharmacology / Editorial Board, S.J. Enna (Editor-in-Chief) ... [Et Al.]. Unit12.5. PMID 21956804 DOI: 10.1002/0471141755.Ph1205S22 |
0.46 |
|
| 2003 |
Münk C, Wei G, Yang OO, Waring AJ, Wang W, Hong T, Lehrer RI, Landau NR, Cole AM. The theta-defensin, retrocyclin, inhibits HIV-1 entry. Aids Research and Human Retroviruses. 19: 875-81. PMID 14585219 DOI: 10.1089/088922203322493049 |
0.484 |
|
| 2003 |
Mariani R, Chen D, Schröfelbauer B, Navarro F, König R, Bollman B, Münk C, Nymark-McMahon H, Landau NR. Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell. 114: 21-31. PMID 12859895 DOI: 10.1016/S0092-8674(03)00515-4 |
0.504 |
|
| 2003 |
Golding H, Aliberti J, King LR, Manischewitz J, Andersen J, Valenzuela J, Landau NR, Sher A. Inhibition of HIV-1 infection by a CCR5-binding cyclophilin from Toxoplasma gondii. Blood. 102: 3280-6. PMID 12855560 DOI: 10.1182/Blood-2003-04-1096 |
0.385 |
|
| 2003 |
Chowdhury IH, Wang XF, Landau NR, Robb ML, Polonis VR, Birx DL, Kim JH. HIV-1 Vpr activates cell cycle inhibitor p21/Waf1/Cip1: a potential mechanism of G2/M cell cycle arrest. Virology. 305: 371-7. PMID 12573582 DOI: 10.1006/Viro.2002.1777 |
0.368 |
|
| 2003 |
Kootstra NA, Münk C, Tonnu N, Landau NR, Verma IM. Abrogation of postentry restriction of HIV-1-based lentiviral vector transduction in simian cells Proceedings of the National Academy of Sciences of the United States of America. 100: 1298-1303. PMID 12547912 DOI: 10.1073/Pnas.0337541100 |
0.528 |
|
| 2002 |
Münk C, Brandt SM, Lucero G, Landau NR. A dominant block to HIV-1 replication at reverse transcription in simian cells. Proceedings of the National Academy of Sciences of the United States of America. 99: 13843-8. PMID 12368468 DOI: 10.1073/Pnas.212400099 |
0.533 |
|
| 2002 |
Si Q, Kim MO, Zhao ML, Landau NR, Goldstein H, Lee S. Vpr- and Nef-dependent induction of RANTES/CCL5 in microglial cells. Virology. 301: 342-53. PMID 12359436 DOI: 10.1006/Viro.2002.1613 |
0.505 |
|
| 2002 |
Landau NR. A cellular cofactor in HIV-1 assembly: INI1 is also an "outtie". Trends in Pharmacological Sciences. 23: 252-3. PMID 12084624 DOI: 10.1016/S0165-6147(02)02021-7 |
0.54 |
|
| 2002 |
Brandt SM, Mariani R, Holland AU, Hope TJ, Landau NR. Association of chemokine-mediated block to HIV entry with coreceptor internalization. The Journal of Biological Chemistry. 277: 17291-9. PMID 11782464 DOI: 10.1074/jbc.M108232200 |
0.375 |
|
| 2002 |
Reed M, Mariani R, Sheppard L, Pekrun K, Landau NR, Soong NW. Chimeric human immunodeficiency virus type 1 containing murine leukemia virus matrix assembles in murine cells. Journal of Virology. 76: 436-43. PMID 11739711 DOI: 10.1128/Jvi.76.1.436-443.2002 |
0.524 |
|
| 2001 |
Mariani R, Rasala BA, Rutter G, Wiegers K, Brandt SM, Kräusslich HG, Landau NR. Mouse-human heterokaryons support efficient human immunodeficiency virus type 1 assembly. Journal of Virology. 75: 3141-51. PMID 11238841 DOI: 10.1128/Jvi.75.7.3141-3151.2001 |
0.504 |
|
| 2000 |
di Marzio P, Mariani R, Lui R, Thomas EK, Landau NR. Soluble CD40 ligand induces beta-chemokine production by macrophages and resistance to HIV-1 entry. Cytokine. 12: 1489-95. PMID 11023663 DOI: 10.1006/Cyto.1999.0594 |
0.408 |
|
| 2000 |
Townson JR, Graham GJ, Landau NR, Rasala B, Nibbs RJB. Aminooxypentane addition to the chemokine macrophage inflammatory protein-1αP increases receptor affinities and HIV inhibition Journal of Biological Chemistry. 275: 39254-39261. PMID 11005816 DOI: 10.1074/Jbc.M006768200 |
0.508 |
|
| 2000 |
Mariani R, Rutter G, Harris ME, Hope TJ, Kräusslich HG, Landau NR. A block to human immunodeficiency virus type 1 assembly in murine cells. Journal of Virology. 74: 3859-70. PMID 10729160 DOI: 10.1128/Jvi.74.8.3859-3870.2000 |
0.533 |
|
| 1999 |
Landau NR. HIV recent advances in AIDS research: genetics, molecular biology and immunology. Current Opinion in Immunology. 11: 449-50. PMID 10448145 DOI: 10.1016/S0952-7915(99)80075-2 |
0.36 |
|
| 1999 |
Nibbs RJB, Yang J, Landau NR, Mao JH, Graham GJ. LD78β, a non-allelic variant of human MIP-1α (LD78α), has enhanced receptor interactions and potent HIV suppressive activity Journal of Biological Chemistry. 274: 17478-17483. PMID 10364178 DOI: 10.1074/Jbc.274.25.17478 |
0.465 |
|
| 1999 |
Paxton WA, Kang S, Liu R, Landau NR, Gingeras TR, Wu L, Mackay CR, Koup RA. HIV-1 infectability of CD4+ lymphocytes with relation to beta-chemokines and the CCR5 coreceptor. Immunology Letters. 66: 71-5. PMID 10203036 DOI: 10.1016/S0165-2478(98)00154-0 |
0.307 |
|
| 1999 |
Mariani R, Wong S, Mulder LC, Wilkinson DA, Reinhart AL, LaRosa G, Nibbs R, O'Brien TR, Michael NL, Connor RI, Macdonald M, Busch M, Koup RA, Landau NR. CCR2-64I polymorphism is not associated with altered CCR5 expression or coreceptor function. Journal of Virology. 73: 2450-9. PMID 9971830 DOI: 10.1128/Jvi.73.3.2450-2459.1999 |
0.407 |
|
| 1999 |
Liu R, Zhao X, Gurney TA, Landau NR. Functional analysis of the proximal CCR5 promoter. Aids Research and Human Retroviruses. 14: 1509-19. PMID 9840284 DOI: 10.1089/Aid.1998.14.1509 |
0.324 |
|
| 1998 |
Bushman F, Landau NR, Emini EA. New developments in the biology and treatment of HIV. Proceedings of the National Academy of Sciences of the United States of America. 95: 11041-2. PMID 9736685 DOI: 10.1073/Pnas.95.19.11041 |
0.413 |
|
| 1998 |
Di Marzio P, Tse J, Landau NR. Chemokine receptor regulation and HIV type 1 tropism in monocyte-macrophages. Aids Research and Human Retroviruses. 14: 129-38. PMID 9462923 DOI: 10.1089/Aid.1998.14.129 |
0.381 |
|
| 1998 |
Landau NR. HIV co-receptor identification: good or bad news for drug discovery? Current Opinion in Immunology. 9: 628-30. PMID 9368769 DOI: 10.1016/S0952-7915(97)80040-4 |
0.358 |
|
| 1997 |
Nibbs RJB, Wylie SM, Yang J, Landau NR, Graham GJ. Cloning and characterization of a novel promiscuous human β-chemokine receptor D6 Journal of Biological Chemistry. 272: 32078-32083. PMID 9405404 DOI: 10.1074/Jbc.272.51.32078 |
0.327 |
|
| 1997 |
Chen Z, Zhou P, Ho DD, Landau NR, Marx PA. Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry. Journal of Virology. 71: 2705-14. PMID 9060623 DOI: 10.1128/JVI.71.4.2705-2714.1997 |
0.384 |
|
| 1997 |
Connor RI, Sheridan KE, Ceradini D, Choe S, Landau NR. Change in coreceptor use correlates with disease progression in HIV-1--infected individuals. The Journal of Experimental Medicine. 185: 621-8. PMID 9034141 DOI: 10.1084/Jem.185.4.621 |
0.485 |
|
| 1997 |
Cheng-Mayer C, Liu R, Landau NR, Stamatatos L. Macrophage tropism of human immunodeficiency virus type 1 and utilization of the CC-CKR5 coreceptor. Journal of Virology. 71: 1657-61. PMID 8995695 DOI: 10.1128/jvi.71.2.1657-1661.1997 |
0.324 |
|
| 1996 |
Endres MJ, Clapham PR, Marsh M, Ahuja M, Turner JD, McKnight A, Thomas JF, Stoebenau-Haggarty B, Choe S, Vance PJ, Wells TN, Power CA, Sutterwala SS, Doms RW, Landau NR, et al. CD4-independent infection by HIV-2 is mediated by fusin/CXCR4. Cell. 87: 745-56. PMID 8929542 DOI: 10.1016/S0092-8674(00)81393-8 |
0.454 |
|
| 1996 |
Huang Y, Paxton WA, Wolinsky SM, Neumann AU, Zhang L, He T, Kang S, Ceradini D, Jin Z, Yazdanbakhsh K, Kunstman K, Erickson D, Dragon E, Landau NR, Phair J, et al. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nature Medicine. 2: 1240-3. PMID 8898752 DOI: 10.1038/Nm1196-1240 |
0.323 |
|
| 1996 |
Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, Horuk R, MacDonald ME, Stuhlmann H, Koup RA, Landau NR. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell. 86: 367-77. PMID 8756719 DOI: 10.1016/S0092-8674(00)80110-5 |
0.463 |
|
| 1996 |
Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, Di Marzio P, Marmon S, Sutton RE, Mark Hill C, Davis CB, Peiper SC, Schall TJ, Littman DR, Landau NR. Identification of a major co-receptor for primary isolates of HIV-1 Nature. 381: 661-666. PMID 8649511 DOI: 10.1038/381661A0 |
0.47 |
|
| 1996 |
Di Marzio P, Choe S, Ebright M, Knoblauch R, Landau NR. Mutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 Vpr. Journal of Virology. 69: 7909-16. PMID 7494303 DOI: 10.1128/Jvi.69.12.7909-7916.1995 |
0.446 |
|
| 1995 |
He J, Landau NR. Use of a novel human immunodeficiency virus type 1 reporter virus expressing human placental alkaline phosphatase to detect an alternative viral receptor. Journal of Virology. 69: 4587-92. PMID 7769729 DOI: 10.1128/JVI.69.7.4587-4592.1995 |
0.433 |
|
| 1995 |
Connor RI, Chen BK, Choe S, Landau NR. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology. 206: 935-44. PMID 7531918 DOI: 10.1006/Viro.1995.1016 |
0.545 |
|
| 1995 |
He J, Choe S, Walker R, Di Marzio P, Morgan DO, Landau NR. Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. Journal of Virology. 69: 6705-11. PMID 7474080 DOI: 10.1128/Jvi.69.11.6705-6711.1995 |
0.424 |
|
| 1994 |
Aiken C, Konner J, Landau NR, Lenburg ME, Trono D. Nef induces CD4 endocytosis: requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell. 76: 853-64. PMID 8124721 DOI: 10.1016/0092-8674(94)90360-3 |
0.332 |
|
| 1993 |
Paxton W, Connor RI, Landau NR. Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of gag and mutational analysis. Journal of Virology. 67: 7229-37. PMID 8230445 DOI: 10.1128/JVI.67.12.7229-7237.1993 |
0.467 |
|
| 1992 |
Landau NR, Littman DR. Packaging system for rapid production of murine leukemia virus vectors with variable tropism. Journal of Virology. 66: 5110-5113. DOI: 10.1128/Jvi.66.8.5110-5113.1992 |
0.33 |
|
| 1990 |
Page KA, Landau NR, Littman DR. Construction and use of a human immunodeficiency virus vector for analysis of virus infectivity Journal of Virology. 64: 5270-5276. PMID 2214018 DOI: 10.1128/Jvi.64.11.5270-5276.1990 |
0.526 |
|
| 1990 |
Page KA, Landau NR, Littman DR. Construction and use of a human immunodeficiency virus vector for analysis of virus infectivity. Journal of Virology. 64: 5270-5276. DOI: 10.1128/jvi.64.11.5270-5276.1990 |
0.309 |
|
| 1988 |
Landau NR, Warton M, Littman DR. The envelope glycoprotein of the human immunodeficiency virus binds to the immunoglobulin-like domain of CD4. Nature. 334: 159-62. PMID 3260352 DOI: 10.1038/334159A0 |
0.328 |
|
| 1984 |
Landau NR, St John TP, Weissman IL, Wolf SC, Silverstone AE, Baltimore D. Cloning of terminal transferase cDNA by antibody screening. Proceedings of the National Academy of Sciences of the United States of America. 81: 5836-40. PMID 6091113 DOI: 10.1073/PNAS.81.18.5836 |
0.404 |
|
| Show low-probability matches. |